Liminal Biosciences announces effectiveness of Registration Statement on Form F-10 and filing of Prospectus Supplement
- Monday, November 18, 2019, 7:38
- PR Newswire
- Add a comment
LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 18, 2019 /PRNewswire/ – Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs in…
About the Author
admin has written 20655 stories on this site.